Related Experiment Video
Updated: Apr 14, 2026
08:52
Measurement of Protein Turnover Rates in Senescent and Non-Dividing Cultured Cells with Metabolic Labeling and Mass Spectrometry
Published on: April 6, 2022
4.2K
Metabolic shifts during aging and pathology
1Department of Pharmacology and Toxicology, State University of New York at Buffalo, NY.
Comprehensive Physiology
|April 17, 2015
Summary
Heart disease is linked to metabolic shifts. Adenosine monophosphate-activated protein kinase (AMPK) helps heart cells adapt to energy stress, crucial for repairing function during aging and disease.
Area of Science:
- Cardiology
- Metabolic Regulation
- Molecular Biology
Background:
- The heart requires high metabolic rates to sustain constant workload.
- Heart diseases are frequently associated with metabolic dysregulation.
- Aging impacts heart metabolism through reduced mitochondrial function and insulin resistance.
Purpose of the Study:
- To review normal cardiac metabolism.
- To discuss metabolic shifts in aging and heart pathologies.
- To explore the role of Adenosine monophosphate-activated protein kinase (AMPK) in regulating cardiac metabolism.
Main Methods:
- Literature review of cardiac metabolism.
- Analysis of metabolic changes during aging and disease states.
- Examination of AMPK's regulatory functions in the heart.
Main Results:
- Cardiac AMPK activation is vital for cardiomyocyte repair during conditions like ischemia and hypertension.
- AMPK promotes ATP generation and reduces ATP depletion.
- AMPK protects the myocardium from dysfunction and apoptosis.
Conclusions:
- Metabolic shifts are central to heart disease development.
- AMPK acts as a key energy sensor, crucial for maintaining cardiac homeostasis.
- Targeting AMPK may offer therapeutic strategies for heart conditions and aging-related metabolic decline.
Related Concept Videos
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
354
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
354
01:26Aging
1.1K
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
1.1K
01:19The Effect of Aging on Tissues
4.2K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
4.2K
01:37Mitochondria
21.5K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
21.5K
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
352
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
352
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
339
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
339